The aim of this study was to develop a new methodology that is suitable for DNA methylation diagnostics and to demonstrate its clinical applicability. We developed a new anion-exchange column for high-performance liquid chromatography (HPLC) with electrostatic and hydrophobic properties. Both cytosine and thymine, corresponding to methylated and unmethylated cytosine after bisulfite modification, 
The aim of this study was to develop a new methodology that is suitable for DNA methylation diagnostics and to demonstrate its clinical applicability. We developed a new anion-exchange column for high-performance liquid chromatography (HPLC) with electrostatic and hydrophobic properties. Both cytosine and thymine, corresponding to methylated and unmethylated cytosine after bisulfite modification, respectively, are captured by electrostatic interaction and then discriminated from each other by their hydrophobic interactions. The DNA methylation levels of synthetic DNA were quantified accurately and reproducibly within 10 minutes without time-consuming pretreatment of PCR products, and the measured values were unaffected by the distribution of methylated CpG within the synthetic DNA fragments.
When the DNA methylation status of the FAM150A gene, a marker of the CpG island methylator phenotype specific to clear cell renal cell carcinoma (ccRCC), was examined in 98 patients with ccRCC, bulk specimens of tumorous tissue including cancer cells showing DNA methylation of the FAM150A gene were easily identifiable by simply viewing the differentiated chromatograms, even when the cancer cell content was low. Sixteen ccRCC showing DNA methylation more frequently exhibited clinicopathological parameters reflecting tumor aggressiveness (ie, a larger diameter, higher histological grade, vascular involvement, renal vein tumor thrombi, infiltrating growth, tumor necrosis, renal pelvis invasion and higher pathological TNM stage), and had significantly lower recurrence-free and overall survival rates.
These data indicate that HPLC analysis using this newly developed anion-exchange column could be a powerful tool for DNA methylation diagnostics, including prognostication of patients with cancers, in a clinical setting. the cancers themselves and frequently associated with clinicopathological aggressiveness and outcome. 3, 4 Once DNA methylation alterations have occurred during carcinogenesis, they are stably
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preserved on DNA double strands by maintenance methylation involving DNA (cytosine-5)-methyltransferase 1 (DNMT1). 5, 6 Therefore, DNA methylation status in specific regions can be an excellent biomarker for carcinogenetic risk estimation, early diagnosis and prognostication of cancers derived from various organs. 7 In general, clear cell renal cell carcinomas (ccRCC) are curable by nephrectomy at the early stage. 8 However, some ccRCC relapse and metastasize to distant organs, even if resection is considered complete. 9 The effectiveness of any therapy using novel targeting agents is restricted unless relapsed or metastasized tumors are diagnosed early by close follow-up. 10 
| MATERIALS AND METHODS

| Preparation of the column packing material
A reactor equipped with a stirrer was filled with 2000 mL of a 3% w/w aqueous solution of polyvinyl alcohol (Nippon Synthetic Chemical Industry, Osaka, Japan), and a mixture of 200 g tetraethylene glycol dimethacrylate (Shin Nakamura Chemical, Wakayama, Japan), 100 g triethylene glycol dimethacrylate (Shin Nakamura Chemical), 100 g glycidyl methacrylate (Wako Pure Chemical Industries, Osaka, Japan) and 1 g benzoyl peroxide (Kishida Chemical, Tokyo, Japan) was added to the solution. The contents were heated to 80°C with stirring and polymerized at that temperature for 1 hour in a nitrogen atmosphere. In this initial step, polymer particles with hydrophobic properties were formed.
Subsequently, a monomer solution of 100 g ethyl methacrylate trimethyl ammonium chloride (Wako Pure Chemical Industries) dissolved in 100 mL ion-exchange water was added to the reactor, and the contents were polymerized at 80°C for 2 hour in a nitrogen atmosphere to prepare a polymerization composite. This composite was rinsed with ion-exchange water and then with acetone. In this second step, polymer chains with quaternary ammonium groups were introduced onto the surface of the polymer particles.
Finally, 10 g of polymer particles were dispersed in 100 mL ionexchange water to prepare an unreacted slurry. Next, 10 mL N,Ndimethylamino propyl amine (Wako Pure Chemical Industries) was added to the slurry with stirring, and the contents were allowed to react at 70°C for 4 hour. After completion of the reaction, the supernatant was removed using a centrifugal separator, Himac CR20G (Hitachi Koki, Tokyo, Japan), and the remaining contents were rinsed with ion-exchange water. After rinsing, an additional supernatant was removed using a centrifugal separator. Rinsing with ion-exchange water was then performed an additional 4 times. In this final step, tertiary amino groups were introduced onto the surface of the polymer particles. Thus, as shown in Figure 1 , newly designed anion-exchange packing materials with electrostatic and hydrophobic properties were prepared. The average particle size was 10 lm, as measured using AccuSizer 780 (Particle Sizing Systems, Florida, USA), an instrument for determination of particle size distribution. The presence or absence of vascular involvement was examined microscopically on slides stained with H&E and Elastica van Gieson.
| Chromatographic analysis
The presence or absence of tumor thrombi in the main trunk of the renal vein was examined macroscopically. The clinicopathological characteristics of the ccRCC in the present study are summarized in Table S1 . All 98 ccRCC had been included in our previous studies, 11, 16 and 84 and 14 of them were diagnosed as CIMP-negative and CIMP-positive, respectively (4 of the ccRCC in the previous study were not included in the present study due to a shortage of genomic DNA samples).
This study was approved by the Ethics Committees of the National Cancer Center, Tokyo and Keio University School of Medicine, and was performed in accordance with the Declaration of Helsinki. All patients provided written informed consent prior to inclusion in the study.
| Bisulfite modification and PCR
Tissue specimens were taken and frozen immediately after surgical removal and then stored in liquid nitrogen until DNA extraction.
High-molecular-weight DNA was extracted from the fresh-frozen tissue samples using phenol-chloroform followed by dialysis. One microgram of genomic DNA was subjected to bisulfite treatment using an EpiTect Bisulfite Kit (QIAGEN GmbH, Hilden, Germany), in accordance with the manufacturer's protocol. The primer positions for PCR encompassing the promoter region of the FAM150A gene are indicated by double underlining in Table 1 . A portion of each PCR product was subjected to 3% agarose gel electrophoresis and visualized by staining with ethidium bromide to confirm the amplification, after which the PCR products were subjected to chromatographic analysis.
| Statistics
The linearity of retention times and cytosine contents was examined by correlation analysis. Differences in retention times were evaluated by t test. Correlations between DNA methylation status and clinicopathological parameters were examined by Wilcoxon rank sum test and Fisher's exact test. Survival curves of patients were generated using the Kaplan-Meier method, and the differences were compared by log-rank test. Statistical analyses were performed using programming language R and IBM SPSS Statistics for Windows, version 24.0 (IBM, Armonk, NY, USA). Differences at P-value of <.05 were considered significant.
| RESULTS
| Determination of quantitativeness and
reproducibility of the newly developed highperformance liquid chromatography column using synthetic DNA fragments Synthetic DNA fragments 1, 3, 5, 6, 7, 8, 9 and 10 corresponding to the sequences after bisulfite modification of 0%, 25% 50%, 75% and 100% methylated promoter regions (Table 1) | 1693 (50%) methylated CpG dinucleotides scattered in various positions (Table 1) , completely overlapped each other, indicating that the retention time was not affected by the positions of methylated CpG (Figure 2A,B) .
To confirm whether this HPLC method is reproducible, we carried out a within-run reproducibility test using PCR products obtained from Fragments 2, 3 and 4 corresponding to DNA methylation levels of 20%, 25% and 30%, respectively (Table 1) , which were around the cut-off value (27.2%) of the DNA methylation level of the FAM150A gene for discrimination of more aggressive CIMP-positive ccRCC from CIMP-negative ccRCC in our previous study using specimens of tumorous tissue and MassARRAY analysis. 16 After 10 measurements were taken for each fragment, excellent concordance of the retention time for each fragment was revealed ( Figure 2D ), indicating the reproducibility of HPLC analysis using the newly developed column. In addition, it was revealed that a difference in methylation level of 5% (ie, would be statistically distinguishable ( Figure 2D ) in a clinically feasible setting.
| High-performance liquid chromatography analysis of clear cell renal cell carcinoma tissue specimens
The FAM150A gene is a CIMP marker gene showing a high area under the curve value (0.968) in receiver operating characteristic analysis for discrimination of CIMP-positive ccRRC from CIMPnegative ccRCC. 16 In the present study, 384-bp PCR products encompassing the promoter region of the FAM150A gene from the 98 ccRCC were subjected to HPLC analysis. PCR products from synthetic DNA fragments 1 and 10 with methylation levels of 0% and 100%, respectively (Table 1) , were measured simultaneously as control samples. Representative chromatograms are shown in Figure 3A . Eighty-two ccRCC showed a single peak that had retention times similar to the unmethylated DNA control (eg, Case 3 in Figure 3A ). In 7 ccRCC, a single peak with a shoulder was observed, as Cases 84 and 89 in Figure 3A . In 9 ccRCC, a bimodal peak pattern consisting of 2 peaks with retention times similar to the unmethylated and methylated DNA was observed (eg, Case 91
in Figure 3A) . Chromatograms of all 98 ccRCC examined are shown in Figure S1 .
The differential patterns of Figure 3A are shown in Figure 3B . All 82 chromatograms showing "a single peak" pattern were converted to differential curves with a single upward convex shape as in Case 3
in Figure 3B . In contrast, chromatograms with "a bimodal peak" pattern were converted to differential curves with 2 upward convex portions as in Case 91 in Figure 3B . Furthermore, all 7 chromatograms
showing "a single peak with a shoulder" pattern were converted to differential curves with 2 upward convex portions without exception (Cases 84 and 89 in Figure 3B ). Thus, we were able to clearly stratify ccRCC into 2 groups, those showing the "one upward convex pat- The recurrence-free and overall survival rates of patients in the "two upward convex pattern" group were significantly lower than those of patients in the "one upward convex pattern" group ( Figure 4 ).
| DISCUSSION
Ion-exchange HPLC is widely used for simple and quick separation analysis of biopolymers such as nucleic acids, proteins and polysaccharides. [22] [23] [24] [25] However, only a few reports have described analysis of DNA methylation using ion-exchange HPLC, as it is not easy to separate cytosine and thymine corresponding to methylated and unmethylated cytosine after bisulfite modification, respectively, using an ordinary ion-exchange column which relies on electrostatic prop- (Table 1 ). Error bar: SD the surface of the polymer particles. Thereafter, the hydrophobicity of the polymer particles plays a role in discrimination between cytosine derived from methylated CpG and thymine derived from unmethylated CpG within the PCR products. Although the amounts of negative charge from the phosphate groups in cytosine and thymine are the same, hydrophobic interaction between the polymer particles and the PCR products containing thymine is stronger due to the methyl group at the 5 0 position of the pyrimidine ring in comparison with that between the polymer particles and the PCR products containing cytosine.
It was found that the novel HPLC column has excellent quantitativeness ( Figure 2C ). Synthetic DNA fragments 5, 6, 7 and 8, all
showing 50% methylation (Table 1) , showed the same retention times regardless of differences in the positions of methylated CpG dinucleotides within the target sequence (Figure 2A,B) . Even though methylated CpGs are distributed unevenly, it is likely that the interaction between the packing materials and PCR products are averaged out by isotropic behavior while passing through the column.
Therefore, the new HPLC column can be useful for DNA methylation analysis regardless of the sequences of the target genes. Subsequently, in Figure 2D , 10 measurements in a within-run reproducibility test revealed excellent reproducibility, and differences in methylation level of only 5% were clearly distinguishable. In addition, we have confirmed that the DNA methylation levels of the FAM150A gene quantified using the new HPLC column are in excellent accordance with those evaluated by the conventional MassAR-RAY method ( Figure S2 ).
Another HPLC method, denaturing HPLC (DHPLC), is an ion-pair reverse-phase HPLC technique that can detect DNA methylation at a specific partial denaturation temperature. 26, 27 Some cancer researchers have reported that the DHPLC method is able to detect DNA methylation of the promoter region of tumor suppressor genes. [28] [29] [30] However, because heteroduplex formation is necessary during analysis, the total analysis time is prolonged. In addition, the shapes of the peaks and retention time changed appreciably with a difference in column temperature of only 1°C ( Figure S3A ). Furthermore, even if the total number of methylated CpG in the target sequence is the same (20 CpG [50% methylation], Table 1 ), the retention time of Fragments 5-8 is changed considerably due to differences in the positions of the methylated CpG ( Figure S3B ), resulting in inaccurate measurement of the DNA methylation level when the DHPLC method is used. In contrast, use of our anion-exchange HPLC method makes it possible to directly apply PCR products without any time-consuming preanalytic procedures, and the analysis can be completed within 10 minutes (Figure 2A,B) . The newly developed column can yield reproducible data using a conventional HPLC device without strict temperature control.
Finally, we applied our newly developed HPLC method to analysis of DNA methylation status using tissue samples. Three types of peak pattern were observed: a "single peak," a "single peak with a shoulder" and a "bimodal peak" ( Figure 3A ). Because ccRCC are hypervascular tumors, as shown in Figure S4 , As shown in Figure S5 , it was confirmed that this HPLC method was able to detect at least a 5% mixture of fully methylated DNA by simply viewing the differential curve. Although the 1% mixture could not be detected in this setting, the discriminability may be improved sufficiently for detection of a 1% content of fully methylated DNA by introduction of fluorescence detection for PCR products tagged with fluorescent substances. In comparison to ordinary methods, such as MassARRAY and pyrosequencing, for which the reliability of measured values of less than 10% is restricted, simple and reliable F I G U R E 3 High-performance liquid chromatography (HPLC) analysis using the newly developed anion-exchange column for tissue specimens of clear cell renal cell carcinoma (ccRCC). A, Representative chromatograms. PCR products of 384 bp encompassing the promoter region of the FAM150A gene from the 98 ccRCC were subjected to HPLC analysis. Case 3 ccRCC showed a single peak with retention times similar to the unmethylated DNA control. In Cases 84 and 89 ccRCC, a single peak with a shoulder was observed. In Case 91 ccRCC, a bimodal peak pattern consisting of 2 peaks which had retention times similar to the unmethylated and methylated DNA was observed.
Chromatograms of all of the 98 ccRCC examined are shown in Figure S1 . B, Differential processing of the chromatograms. The differential patterns of chromatograms in (A) are shown in this panel. In Case 3, a chromatogram showing a "single peak" pattern was converted to a differential curve with 1 upward convex portion. In Cases 84 and 89, chromatograms showing a "single peak with a shoulder" pattern were converted to differential curves with 2 upward convex portions. In Case 91, a "bimodal peak" pattern chromatogram was converted to a differential curve with 2 upward convex portions T A B L E 2 Correlation between DNA methylation status ("one upward convex pattern" vs "two upward convex pattern") and clinicopathological parameters of clear cell renal cell carcinomas If the tumor showed heterogeneity, findings in the predominant area were described.
d
If the tumor showed heterogeneity, the most aggressive features of the tumor were described.
detection of only a small number of cancer cells having methylated DNA using our HPLC system would be advantageous for analysis of clinical specimens.
The present study using our newly developed HPLC column revealed a "two upward convex pattern" of the differential curve in 16 ccRCC. These 16 ccRCC including cancer cells showing various degree of DNA methylation of the FAM150A gene showed a significantly higher incidence of clinicopathological features reflecting tumor aggressiveness (Table 2 ) and shorter recurrence-free and overall survival times than 82 ccRCC showing a "one upward convex pattern" (Figure 4 ). In our previous study, 14 ccRCC included in the present study were found to be CIMP-positive using genome-wide DNA methylation analysis by Infinium assay 11 and DNA methylation quantification of the 7 ccRCC-specific CIMP marker genes using the MassARRAY system. 16 Although the present stratification of 16
ccRCC showing 2 upward convex portions showed appreciable overlap with the previous stratification of CIMP-positive ccRCC, the present "two upward convex pattern" can be identified by simple and quick analysis of only one gene, FAM150A. respectively. Because our HPLC method is able to detect 5% DNA methylation ( Figure S5 ), 16%-58% of cancer cells in liquid biopsy samples would be detectable using our system. In addition, unlike ordinary methods that tend to quantify the different DNA methylation levels in cancer cells and contaminating blood cells as a whole, our HPLC system that quantifies the various levels of DNA methylation in individual cell lineages would be more suitable for liquid biopsy samples containing CTC and contaminating blood cells. Moreover, pharmacoepigenetic studies have recently revealed that drug response can be predicted based on the DNA methylation profiles of blood cells, because germline DNA methylation status regulates the expression levels of drug-metabolizing enzymes and drug transporters. 37, 38 Therefore, quantification of DNA methylation using our HPLC system would be applicable to the prediction of anti-cancer drug response.
Unlike clinical sequencing and RNA sequencing, our HPLC method has been developed for quantification of DNA methylation.
DNA methylation alterations accumulate upon exposure to carcinogenetic factors, even in precancerous conditions, and generally pre- by covalent bonds. Therefore, DNA methylation levels at appropriate marker CpG sites, which can be quantified using our HPLC method, would appear to be more optimal biomarkers. Moreover, our HPLC method has excellent cost-effectiveness. These characteristics make our method outstanding in a clinical setting.
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